Clinical TrialsSearch results
Number of results: 395
Other
- Study for the effectiveness of intensive therapy for diabetic nephropathy in unblinded, randomized intergroup comparison study.
- Diabetic Nephropathy
- Okayama University Hospital
- 2005-11-16
Other
- Home blood pressure for diabetic nephropathy
- diabetic nephropathy
- National Hospital Organization
- 2007-09-01
Other
- Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT)
- Diabetic peripheral neuropathy
- The Aldose Reductase Inhibitor-Diabetes Complications Trial (ADCT) Study Group
- 2007-02-20
Other
- Trial in diabetic ulcer Using basic Fibroblast Growth Factor(KCB-1)
- Diabetic ulcer
- KAKEN PHARMACEUTICAL CO., LTD.
- 2007-09-21
Other
- Japanese Diastolic Heart Failure Study
- Diastolic heart failure
- J-DHF Study group
- 2006-02-01
Other
- A phase II study of the combination of Rituximab, Mitoxantrone, Etoposide, and Prednisolone for relapsed elderly patients with diffuse large B-cell lymphoma (R-MEP07)
- Diffuse large B-cell lymphoma
- Clinical Hematology Study Group of National Hospital Organization (CHSG-NHO)
- 2008-03-01
Other
- Clinical examination about immunoadsorption therapy for dilated cardiomyopathy
- dilated cardiomyopathy
- Department of Cardiology, Kitasato Institute Hospital
- 2007-03-01
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Importance of checking exon skipping events prior to clinical trials using systemically delivered antisense morpholino in Duchenne muscular dystrophy patients
- Duchenne muscular dystrophy
- Kumamoto University
- 2009-06-01
Other
- Prospective study of wide excision and endocrine therapy WithOut RadioTHerapy (WORTH) for node-negative estrogen receptor positive early breast cancer with histologically negative margins (WORTH trial)(No.4)
- early breast cancer
- a Grant-in-Aid for research of cancer treatment from the Ministry of Health, Labor and Welfare of Japan (No.21-7-4)
- 2006-12-10